Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H F Chambers

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Proceedings of the National Academy of Sciences of the United States of America|July 5, 2001
Chemokine receptor 2 serves an early and essential role in resistance to Mycobacterium tuberculosisW Peters, H M Scott, H F Chambers, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1985
Pefloxacin therapy for experimental endocarditis caused by methicillin-susceptible or methicillin-resistant strains of Staphylococcus aureusP M Sullam, M G Täuber, C J Hackbarth, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1995
Can penicillins and other beta-lactam antibiotics be used to treat tuberculosis?H F Chambers, D Moreau, D Yajko, et al.
The American Journal of Medicine|September 30, 1998
A randomized comparison of the safety and efficacy of once-daily gentamicin or thrice-daily gentamicin in combination with ticarcillin-clavulanateD N Gilbert, B L Lee, R J Dworkin, et al.
International Journal of Antimicrobial Agents|August 26, 1999
The role of glycopeptide antibiotics in the treatment of infective endocarditisR N Grüneberg, F Antunes, H F Chambers, et al.
The Journal of Infectious Diseases|August 7, 1999
A randomized clinical trial of mupirocin in the eradication of Staphylococcus aureus nasal carriage in human immunodeficiency virus diseaseJ N Martin, F Perdreau-Remington, M Kartalija, et al.
The Journal of Infectious Diseases|May 6, 2017
White Paper: Developing Antimicrobial Drugs for Resistant Pathogens, Narrow-Spectrum Indications, and Unmet NeedsHelen W Boucher, Paul G Ambrose, H F Chambers, et al.
The Journal of Infectious Diseases|July 1, 1987
Risk of transmitting the human immunodeficiency virus, cytomegalovirus, and hepatitis B virus to health care workers exposed to patients with AIDS and AIDS-related conditionsJ L Gerberding, C E Bryant-LeBlanc, K Nelson, et al.
Circulation|December 22, 1998
Diagnosis and management of infective endocarditis and its complicationsA S Bayer, A F Bolger, K A Taubert, et al.
Mbio|March 24, 2022
Comparison of the Respiratory Resistomes and Microbiota in Children Receiving Short versus Standard Course Treatment for Community-Acquired PneumoniaM M Pettigrew, J Kwon, J F Gent, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Proceedings of the National Academy of Sciences of the United States of America|July 5, 2001
Chemokine receptor 2 serves an early and essential role in resistance to Mycobacterium tuberculosisW Peters, H M Scott, H F Chambers, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1985
Pefloxacin therapy for experimental endocarditis caused by methicillin-susceptible or methicillin-resistant strains of Staphylococcus aureusP M Sullam, M G Täuber, C J Hackbarth, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1995
Can penicillins and other beta-lactam antibiotics be used to treat tuberculosis?H F Chambers, D Moreau, D Yajko, et al.
The American Journal of Medicine|September 30, 1998
A randomized comparison of the safety and efficacy of once-daily gentamicin or thrice-daily gentamicin in combination with ticarcillin-clavulanateD N Gilbert, B L Lee, R J Dworkin, et al.
International Journal of Antimicrobial Agents|August 26, 1999
The role of glycopeptide antibiotics in the treatment of infective endocarditisR N Grüneberg, F Antunes, H F Chambers, et al.
The Journal of Infectious Diseases|August 7, 1999
A randomized clinical trial of mupirocin in the eradication of Staphylococcus aureus nasal carriage in human immunodeficiency virus diseaseJ N Martin, F Perdreau-Remington, M Kartalija, et al.
The Journal of Infectious Diseases|May 6, 2017
White Paper: Developing Antimicrobial Drugs for Resistant Pathogens, Narrow-Spectrum Indications, and Unmet NeedsHelen W Boucher, Paul G Ambrose, H F Chambers, et al.
The Journal of Infectious Diseases|July 1, 1987
Risk of transmitting the human immunodeficiency virus, cytomegalovirus, and hepatitis B virus to health care workers exposed to patients with AIDS and AIDS-related conditionsJ L Gerberding, C E Bryant-LeBlanc, K Nelson, et al.
Circulation|December 22, 1998
Diagnosis and management of infective endocarditis and its complicationsA S Bayer, A F Bolger, K A Taubert, et al.
Mbio|March 24, 2022
Comparison of the Respiratory Resistomes and Microbiota in Children Receiving Short versus Standard Course Treatment for Community-Acquired PneumoniaM M Pettigrew, J Kwon, J F Gent, et al.
Pageof 8